Elenco delle Pubblicazioni dell’Area Cardiovascolare suddivise per anno di pubblicazione.
Gruppo MultiMedica
Pubblicazioni
Exosome-based immunomodulation during aging: a nano-perspective on inflamm-aging.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Mar 1
Newspaper: Mech Ageing Dev.
Anno: 2017
Volume: 2017 Mar 1
Newspaper: Mech Ageing Dev.
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 May;33(4)
Newspaper: DIABETES-METABOLISM RESEARCH AND REVIEWS
Anno: 2017
Volume: 2017 May;33(4)
Newspaper: DIABETES-METABOLISM RESEARCH AND REVIEWS
Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Nov 29
Newspaper: Eur J Intern Med.
Anno: 2017
Volume: 2017 Nov 29
Newspaper: Eur J Intern Med.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Aug 24;377(8)
Newspaper: N Engl J Med.
Anno: 2017
Volume: 2017 Aug 24;377(8)
Newspaper: N Engl J Med.
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Nov;5(11)
Newspaper: Lancet Diabetes Endocrinol.
Anno: 2017
Volume: 2017 Nov;5(11)
Newspaper: Lancet Diabetes Endocrinol.
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Nov;5(11)
Newspaper: Lancet Diabetes Endocrinol.
Anno: 2017
Volume: 2017 Nov;5(11)
Newspaper: Lancet Diabetes Endocrinol.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Sep 28;377(13)
Newspaper: N Engl J Med.
Anno: 2017
Volume: 2017 Sep 28;377(13)
Newspaper: N Engl J Med.
EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Dec 4
Newspaper: RETINA.
Anno: 2017
Volume: 2017 Dec 4
Newspaper: RETINA.
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Jul 25
Newspaper: Diabetes Metab.
Anno: 2017
Volume: 2017 Jul 25
Newspaper: Diabetes Metab.
Central role of the p53 pathway in the noncoding-RNA response to oxidative stress.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Dec 12
Newspaper: Aging (Albany NY).
Anno: 2017
Volume: 2017 Dec 12
Newspaper: Aging (Albany NY).
Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Jan 13
Newspaper: Obes Rev.
Anno: 2017
Volume: 2017 Jan 13
Newspaper: Obes Rev.
Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
Line of research: Diabete e sue complicanze, obesità e malattie metaboliche
Anno: 2017
Volume: 2017 Jan 16
Newspaper: Nutr Metab Cardiovasc Dis.
Anno: 2017
Volume: 2017 Jan 16
Newspaper: Nutr Metab Cardiovasc Dis.
